文献速递糖尿病

1型糖尿病中血糖对心血管结局风险影响的中介因素:DCCT/EDIC研究

Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
PubMed 文献 · Diabetes Care · 2019-03-20

DCCT/EDIC研究纳入1441例1型糖尿病患者,随机接受强化或常规治疗并长期随访,分析传统心血管危险因素对HbA1c与CVD风险关联的中介比例。结果显示仅少数因素单独解释超过10%的效应,多变量模型下传统因素合计中介约50%,但HbA1c与CVD风险的关联仍高度显著。

要点

  • 传统心血管危险因素合计仅中介约50%的HbA1c对CVD风险效应。
  • 校正传统因素后,HbA1c与CVD风险仍保持高度显著关联。
  • 1型糖尿病需在强化降糖同时积极管理非血糖心血管危险因素。

核心结论

  • HbA1c与多种传统心血管危险因素相关,但后者不能完全解释HbA1c对CVD风险的影响。
  • 对1型糖尿病患者,应在强化血糖管理的同时积极管理传统非血糖心血管危险因素。

研究设计与样本

  • DCCT随机对照试验纳入1441例1型糖尿病患者,随机接受强化或常规治疗。
  • EDIC观察性随访纳入96%存活DCCT队列,随访超过27年后94%存活者仍积极参与。

主要发现

  • 校正年龄后,仅少数因素(如脉搏、甘油三酯、白蛋白排泄率)单独解释超过10%的血糖对CVD风险效应。
  • 多变量模型中,这些传统危险因素合计中介高达约50%的血糖对CVD风险效应。
  • 校正这些危险因素后,HbA1c与CVD风险的关联仍高度显著。

临床怎么用

  • 在1型糖尿病管理中,不能仅依赖降糖治疗,应同时评估和管理传统非血糖心血管危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study has demonstrated the major role of hyperglycemia as a risk factor for clinical cardiovascular outcomes in type 1 diabetes (T1D). We assessed whether and to what extent the effect of glycemia is mediated by other established cardiovascular disease (CVD) risk factors. RESEARCH DESIGN AND METHODS: In the DCCT, 1,441 participants were randomized to receive either intensive or conventional diabetes therapy. The EDIC observational follow-up study enrolled 96% of the surviving DCCT cohort with 94% of the survivors still actively participating after more than 27 years of follow-up. Mediation of the effect of glycemia, as captured by HbA1c, on the subsequent CVD risk was quantified using the relative change in the CVD risk associated with HbA1c between models without and with the potential mediator. RESULTS: Adjusted for age, only a few factors (e.g., pulse, triglycerides, albumin excretion rate) explained more than 10% of the effect of glycemia on CVD risk when considered individually. In multivariable models, these traditional risk factors together mediated up to ∼50% of the effect of glycemia on the risk of CVD. However, the association between HbA1c and the risk of CVD remained highly significant even after adjustment for these risk factors. CONCLUSIONS: While HbA1c is associated with many traditional CVD risk factors, its association with these factors alone cannot explain its effects on risk of CVD. Consequently, aggressive management of traditional nonglycemic CVD risk factors, coupled with aggressive glycemic management, is indicated for individuals with type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bebu I, Braffett BH, Orchard TJ, et al. Mediation of the Effect of Glycemia on the Risk of CVD Outcomes in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2019. PMID: 30894365. doi:10.2337/dc18-1613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。